Ucirvinecath Lab Essentials Program - 2015

Ucirvinecath Lab Essentials Program - 2015

UCIrvineCath Lab Essentials Program - 2015

Presented by

University of California, Irvine

School of Medicine

Division of Cardiology

January 24,2015

UCIrvineCath Lab Essentials Program - 2015

Doubletree Hotel Anaheim/OrangeCounty

100 The City Drive, Orange, CA

______

Course Description

The UCI Cath Lab Essentials Program is designed to expand upon and fill knowledge gaps brought to the attention of the cath lab faculty by the nurses and staff working in the cath lab. Cath lab nurses/staff require periodic updates on procedure techniques, basic hemodynamics, cardiovascular pathophysiology, angiography, and novel interventional procedures in this dynamic and changing field. The Society of Invasive Cardiac Professionals recommends periodic updates on current and new cath lab techniques and equipment.

Learning Objectives:

At the conclusion of this activity the participant should be able to:

  1. Obtain a basic understanding of hemodynamics in the cardiac Cath Lab, identify pressure measurement, artifacts and the application of pressure waveforms to the diagnosis of valvular abnormalities.
  2. Review the indications and contraindications for cardiac catheterization, identify complications and their management and understand the use of transfemoral and transradial catheterization techniques.
  3. Identify new methods for interventional cardiology procedures, the use of hemodynamic support devices, coronary stents, fractional flow reserve (FFR), intravascular ultrasound (IVUS) and optical coherence tomography (OCT).

Target Audience: Catheterization lab nurses and technicians, cardiovascular nurses, and students and fellows-in-training and local community hospital physicians.

Accreditation Statement: The University of California, Irvine School of Medicine, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Designation Statement: The University of California, Irvine School of Medicine designates this live activity for a maximum of6AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity. ASRT Designation: The American Society of Radiologic Technologists (ASRT) has approved this live activity for a maximum of 7 Category A Credits. Participants must complete the entire activity as designed and approvd to earn the credit. Disclosure Statement:It is the policy of the University of California, Irvine School of Medicine and the University of California CME Consortium to ensure balance, independence, objectivity and scientific rigor in all CME activities. Full disclosure of conflict resolution will be made in writing via handout materials or syllabus.

California Assembly Bill 1195

This activity is in compliance with California Assembly Bill 1195, which requires continuing medical education activities with patient care components to include curriculum in the subjects of cultural and linguistic competency. For specific information regarding Bill 1195 and definitions of cultural and linguistic competency, please visit the CME website at .

SYLLABUS DISCLOSURE

UCIRVINECATH LAB ESEENTIALS PROGRAM- 2015

All faculty presenting at activities certified for CME must complete the Faculty Disclosure form regardless of whether or not the activity is receiving commercial support. Documentation of disclosures to participants is required in this format.

UCI OCME requires that the content of CME activities and related materials provide balance, independence, objectivity, and scientific rigor. Planning must be free of the influence or control of a commercial entity, and promote improvements or quality in healthcare. It is the policy of the UCI Office of Continuing Medical Education to insure balance, independence, objectivity, and scientific rigor in all its educational activities. All faculty participating in UCI OCME sponsored CME programs are expected to disclose to the activity participants any real or apparent conflict(s) of interest that may have a direct bearing on the subject matter of the continuing education activity. This pertains to relationships with pharmaceutical companies, biomedical device manufacturers, or other corporations whose products or services are related to the course content. The intent of this policy is identifying potential conflicts of interest so participants can form their own judgments with full disclosure of the facts. It remains for the participants to determine whether the speaker’s outside interests reflect a possible bias in either the exposition or the conclusions presented.

Speaker Name / Name of Commercial Interest / Nature of Relevant Relationship / Conflict Resolution
Morton J. Kern, MD / ACIST Medical Systems
OPSENS
VolcanoTherapeutics
St. Jude Medical / Consultant
Consultant
Speaker
Speaker / As course director, I will to the best of my ability ensure that content is independent of com-mercial bias. Presentation has been peer reviewed for evidence base and fair balance. Will not discuss the use of any unlabelled/unapproved drugs or devices.
Pranav Patel, MD / N/A / N/A
Rajesh Banker, MD / N/A / N/A
Teferi Mitiku, MD / N/A / N/A
Alice Perlowski, MD / N/A / N/A
Arnold Seto, MD / N/A / N/A

This educational activity may contain discussion of unlabeled and/or investigational uses of agents that are not approved by the FDA. Please consult the prescribing information for each product.

Speaker Name / Product / Product Use
Morton J. Kern, MD / None
Pranav Patel, MD / None
Rajesh Banker, MD / None
Teferi Mitiku, MD / None
Alice Perlowski, MD / None
Arnold Seto, MD / None

The views and opinions expressed in this activity are those of the faculty and do not necessarily reflect the views of the University of California, Irvine School of Medicine.

Program Faculty

______

COURSE CHAIRS

Morton J. Kern, MD

Professor of Medicine

Chief, Department of Medicine, LBVA

Associate Chief, Division of Cardiology, UCI

Pranav M. Patel, MD

Associate Professor of Medicine

Chief, Division of Cardiology

Director, Cardiac Catheterization Laboratory

University of California, Irvine

UCI – SCHOOL OF MEDICINE FACULTY

Arnold Seto, MD, MPH

Assistant Professor of Medicine

Interim Chief, Cardiology, LBVA

Interventional Cardiologist, LBVA and UCI

Teferi Mitiku, MD

Assistant Professor of Medicine

Electrophysiologist

University of California, Irvine

Alice Perlowski, MD

Assistant Professor of Medicine

Interventional Cardiologist, LBVA and UCI

Rajesh Banker, MD

Assistant Professor of Medicine

Electrophysiologist

University of California, Irvine

UC Irvine Cath Lab Essential Program - 2015

January 24, 2015

DoubleTree Hotel

07:30-07:55Registration with Coffee and Danish

Meet and Greet Faculty

07:55-08:00Welcome RemarksKern

08:00-08:30Patient Preparation, Safety, and Post Procedure CareSeto

08:30-09:00Coronary Angiography: Coronary Anatomy, Kern

Anomalies and the Ventricular Angiograms

09:00-09:30ECG and Arrhythmia in STEMI:Mitiku

What You Should Know

09:30-10:00Essential Skills: Understanding Access and Perlowski

Approach to PAD

10:00-10:15Break

10:15-10:45IVUS, OCT and NIRS: Different Views ofPatel

Atherosclerosis

10:45-11:15Coronary Stenting: The Appropriate use of FFRKern

11:15-11:45Hemodynamics for the Cath Lab and ICUSeto

11:45-12:30Lunch

12:30-1:00Advanced Hemodynamics: Essentials for TAVR Perlowski

and Mitral Valve Disease

1:00-1:30Essentials for Pacemakers and ICDsBanker

1:30-2:00LV Assist Devices for Hemodynamic Support: Patel

IABP, Impella, Tandem Heart

2:00-3:00Case Review and Complications: Kern/Patel

Presentations from Cath Lab Staff and Physicians

3:00Adjourn